Alternatives to Adaptive Biotechnologies

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

Developing novel diagnostics to predict patient response to immunotherapy.

Biotechnology company developing cell and gene therapies for serious diseases.

AI-powered drug discovery platform leveraging nature's chemistry for novel therapeutics.

High-resolution T-cell receptor repertoire analysis for immunological insights and therapeutic development.

Hacking healthcare with CRISPR technology.

Develops a proprietary, stand-alone platform for rapid, lab-grade molecular diagnostics at the point of need.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

AI-powered platform for personalized cell therapy development and manufacturing.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

A precision biotechnology company developing a blood-based platform for early cancer detection and treatment.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.

AI-powered platform for antibody discovery and development to create new medicines.

Biotechnology company specializing in antibody discovery and development with integrated 'Idea to IND' solutions.

A global oncology company developing and commercializing innovative cancer treatments.

Phenomics-driven AI company translating disease biology into precision medicine discoveries.

Developing engineered biologics to harness the immune system for disease treatment.

Clinical-stage genetic medicine company developing AAV-mediated treatments for cardiovascular and Alzheimer's diseases.

Biotechnology company developing gene therapies and regenerative medicine for heart disease.

Biotechnology company developing immuno-neurology therapies for neurodegenerative diseases.

Biopharmaceutical company developing novel therapies for rare and ultra-rare genetic diseases.

Advance every cancer decision.

Adimab is a biotechnology company that discovers and develops therapeutic antibodies using its proprietary yeast-based platform.

PFx Biotech is developing a novel platform for the discovery and development of protein-based therapeutics.

Gene therapy company developing transformative treatments for severe genetic diseases.

Gene therapy company developing treatments for rare inherited diseases.

Mining biological information for transformative peptide medicines.

Ridge Bio is developing a novel gene therapy platform for treating rare genetic diseases.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Mapping and reprogramming the immune system with single-cell biology and AI for therapeutic discovery.

Global life sciences company providing diagnostic and biopharma laboratory services.

A biotechnology company focused on extending healthy human lifespan by targeting the biological causes of aging.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

R&D cloud platform for life sciences, enabling scientific innovation and productivity.

Global marketplace connecting researchers with human biospecimens for life science research.

Alto Neuroscience is a clinical-stage biopharmaceutical company developing precision psychiatry medicines for mental health conditions.

AI-powered spatial biology platform for precision medicine and drug development.

Biosynthesis of cannabinoids and psychedelics using advanced biotechnology.

AI-powered platform for profiling cancer biomarkers from digitized biopsy images.

A clinical-stage biotechnology company developing transformative genome editing medicines for serious diseases.

Biotech company focused on designing and developing novel biological solutions.

Biotechnology company

Lunit is a medical AI company developing AI-powered solutions for cancer diagnostics and therapeutics.

Clinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.

A clinical-stage genome editing company developing novel therapies using CRISPR/Cas9 technology for severe diseases.

Developing human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.

A clinical-stage AI drug discovery company accelerating the development of novel therapeutics for various diseases.

Personalizing cancer care through a novel, physics-informed approach to predict tumor response to therapy.

Freenome is a biotechnology company developing a multi-cancer early detection blood test using machine learning and biology.

SNIPR Biome is a clinical-stage company developing CRISPR-based therapeutics to precisely target and eliminate specific bacteria in the human microbiome.

Develops advanced gene editing and cell therapy solutions for rare genetic diseases.

Omega Therapeutics is developing a new class of programmable medicines called Epigenomic Controllers.

Precision oncology company developing cancer therapies guided by proprietary functional genomics.

Cassidy Bio is an AI-driven company accelerating gene editing therapeutic development with bespoke solutions for faster, smarter R&D decisions.

Valthos is an applied biological intelligence company. We develop and deploy software and AI methods to outsmart biological evolution and ensure that these tools are deployed to safeguard humanity.

AI-powered blood test for early cancer detection and subtyping.

Harnessing genetic data for digital insights in rare and germline disorders.

Personalized medicine startup focused on accurate cancer treatment through advanced diagnostics and functional drug sensitivity testing.

A global biotechnology company discovering, developing, manufacturing, and delivering innovative human therapeutics.